The retinoic acid synthesis gene ALDH1a2 is a candidate tumor suppressor in prostate cancer.

Prostate cancer is the most common cancer among men in the United States, and aberrant DNA methylation is known to be an early molecular event in its development. Here, we have used expression profiling to identify novel hypermethylated genes whose expression is induced by treatment of prostate cancer cell lines with the DNA methyltransferase inhibitor 5-Aza-2'-deoxycytidine (5-aza-dC). Of the 271 genes that were induced by 5-aza-dC treatment, 25 also displayed reduced expression in primary prostate tumors compared with normal prostate tissue, and the decreased expression of only one gene, aldehyde dehydrogenase 1 family, member A2 (ALDH1a2), was also associated with shorter recurrence-free survival. ALDH1a2 encodes an enzyme responsible for synthesis of retinoic acid (RA), a compound with prodifferentiation properties. By immunohistochemistry, we observed that ALDH1a2 was expressed in epithelia from normal prostate but not prostate cancer. Using bisulfite sequencing, we determined that the ALDH1a2 promoter region was significantly hypermethylated in primary prostate tumors compared with normal prostate specimens (P = 0.01). Finally, transfection-mediated reexpression of wild-type ALDH1a2 (but not a presumptive catalytically dead mutant) in the prostate cancer cell line DU145 resulted in decreased colony growth (P < 0.0001), comparable with treatment with either 5-aza-dC or RA. Taken together, our findings implicate ALDH1a2 as a candidate tumor suppressor gene in prostate cancer and further support a role of retinoids in the prevention or treatment of prostate cancer.

[1]  J. Hicks,et al.  Hypermethylation of the human glutathione S-transferase-pi gene (GSTP1) CpG island is present in a subset of proliferative inflammatory atrophy lesions but not in normal or hyperplastic epithelium of the prostate: a detailed study using laser-capture microdissection. , 2003, The American journal of pathology.

[2]  W. Isaacs,et al.  Protection against 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine cytotoxicity and DNA adduct formation in human prostate by glutathione S-transferase P1. , 2001, Cancer research.

[3]  D. Ong,et al.  Retinol conversion to retinoic acid is impaired in breast cancer cell lines relative to normal cells , 2000 .

[4]  Y. Oshika,et al.  P-glycoprotein-mediated acquired multidrug resistance of human lung cancer cells in vivo. , 1996, British Journal of Cancer.

[5]  S. de Vos,et al.  Effects of retinoid X receptor‐selective ligands on profileration of prostate cancer cells , 1997, The Prostate.

[6]  Peter A. Jones,et al.  Advances in Brief Analysis of Gene Induction in Human Fibroblasts and Bladder Cancer Cells Exposed to the Methylation Inhibitor 5-Aza-2-deoxycytidine 1 , 2002 .

[7]  M. Hoque,et al.  Quantitative RARbeta2 hypermethylation: a promising prostate cancer marker. , 2004, Clinical cancer research : an official journal of the American Association for Cancer Research.

[8]  S. Lippman,et al.  Effect of 13-cis-retinoic acid on serum prostate-specific antigen levels in patients with recurrent prostate cancer after radical prostatectomy. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[9]  Matty P. Weijenberg,et al.  A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer , 2002, Nature Genetics.

[10]  N. Greenberg,et al.  Retinoic acid slows progression and promotes apoptosis of spontaneous prostate cancer , 2004, The Prostate.

[11]  J. Warkany,et al.  An analysis of the syndrome of malformations induced by maternal vitamin A deficiency. Effects of restoration of vitamin A at various times during gestation. , 1953, The American journal of anatomy.

[12]  G. Eichele,et al.  Abnormal level of retinoic acid in prostate cancer tissues. , 1996, The Journal of clinical endocrinology and metabolism.

[13]  R. Lotan,et al.  Induction of apoptosis by N-(4-hydroxyphenyl)retinamide and its association with reactive oxygen species, nuclear retinoic acid receptors, and apoptosis-related genes in human prostate carcinoma cells. , 1999, Molecular pharmacology.

[14]  L. Ossowski,et al.  Activation of Rb and decline in androgen receptor protein precede retinoic acid–induced apoptosis in androgen‐dependent LNCaP cells and their androgen‐independent derivative , 1999, Journal of cellular physiology.

[15]  A Yoshida,et al.  Human aldehyde dehydrogenase gene family. , 1998, European journal of biochemistry.

[16]  R. Hayes,et al.  Serum retinal and prostate cancer , 1988 .

[17]  J. Brooks,et al.  Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Z. Hall.  Cancer , 1906, The Hospital.

[19]  R. Vessella,et al.  Inhibition of tumorigenic potential and prostate‐specific antigen expression in LNCaP human prostate cancer cell line by 13‐cis‐retinoic acid , 1994, International journal of cancer.

[20]  N. Picard,et al.  A selective retinoid with high activity against an androgen‐resistant prostate cancer cell type , 1999, International journal of cancer.

[21]  R. Lotan,et al.  Differential expression of nuclear retinoid receptors in normal and malignant prostates. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  J. Herman,et al.  Gene silencing in cancer in association with promoter hypermethylation. , 2003, The New England journal of medicine.

[23]  Rajvir Dahiya,et al.  DNA methylation in prostate cancer. , 2004, Biochimica et biophysica acta.

[24]  G. Schuler.  Pieces of the puzzle: expressed sequence tags and the catalog of human genes , 1997, Journal of Molecular Medicine.

[25]  V. Vasiliou,et al.  Aldehyde dehydrogenase gene superfamily: the 2002 update. , 2003, Chemico-biological interactions.

[26]  M. Sporn,et al.  Prevention of primary prostate cancer in Lobund-Wistar rats by N-(4-hydroxyphenyl)retinamide. , 1991, Cancer research.

[27]  D. Tindall,et al.  Androgen receptor signaling in androgen-refractory prostate cancer. , 2001, Journal of the National Cancer Institute.

[28]  N. Dawson,et al.  Update on hormone-refractory prostate cancer , 2004, Current opinion in urology.

[29]  R. Tibshirani,et al.  Gene expression profiling identifies clinically relevant subtypes of prostate cancer. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[30]  C. Tangen,et al.  Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. , 2004, The New England journal of medicine.

[31]  D. Bostwick,et al.  Cellular and Molecular Pathology of Prostate Cancer Precursors , 2000, Scandinavian journal of urology and nephrology. Supplementum.

[32]  A. Jemal,et al.  Cancer Statistics, 2004 , 2004, CA: a cancer journal for clinicians.

[33]  T. Huang,et al.  Methylation profiling of CpG islands in human breast cancer cells. , 1999, Human molecular genetics.

[34]  M. Becich,et al.  Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  Alan W. Partin,et al.  Management of patients with an increasing prostate-specific antigen after radical prostatectomy , 2004 .

[36]  S. Clark,et al.  High sensitivity mapping of methylated cytosines. , 1994, Nucleic acids research.

[37]  Thomas D. Otto,et al.  Tumour class prediction and discovery by microarray-based DNA methylation analysis , 2002 .

[38]  J. Herman,et al.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[39]  L. M. Luca,et al.  Retinoids and their receptors in differentiation, embryogenesis, and neoplasia. , 1991 .

[40]  P. Chambon,et al.  Genetic evidence that oxidative derivatives of retinoic acid are not involved in retinoid signaling during mouse development , 2002, Nature Genetics.

[41]  David C. Smith,et al.  A phase II trial of all-trans-retinoic acid in hormone-refractory prostate cancer: a clinical trial with detailed pharmacokinetic analysis , 1997, Cancer Chemotherapy and Pharmacology.

[42]  I. Lasnitzki.  The Influence of a Hypervitaminosis on the Effect of 20-Methylcholanthrene on Mouse Prostate Glands Grown In Vitro , 1955, British Journal of Cancer.

[43]  R. Hayes,et al.  Serum retinol and prostate cancer. , 1988, Cancer.

[44]  V. Reuter,et al.  The development of biologic end points in patients treated with differentiation agents: an experience of retinoids in prostate cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[45]  H. Albertsen,et al.  Inhibition of DNA methyltransferase stimulates the expression of signal transducer and activator of transcription 1, 2, and 3 genes in colon tumor cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[46]  P Chambon,et al.  Retinoic acid receptors and retinoid X receptors: interactions with endogenous retinoic acids. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[47]  R. Niles.  Signaling pathways in retinoid chemoprevention and treatment of cancer. , 2004, Mutation research.

[48]  D. Ong,et al.  Retinoic acid biosynthesis by normal human breast epithelium is via aldehyde dehydrogenase 6, absent in MCF-7 cells. , 2001, Cancer research.

[49]  Masatoshi Watanabe,et al.  The Role of Epigenetic Modifications in Retinoic Acid Receptor β2 Gene Expression in Human Prostate Cancers , 2001, Laboratory Investigation.

[50]  M. Rubin,et al.  Molecular genetics of human prostate cancer , 2004, Modern Pathology.

[51]  R. Hayes,et al.  Serum vitamin A and subsequent development of prostate cancer in the first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. , 1990, Cancer research.

[52]  P. Chambon,et al.  The regional pattern of retinoic acid synthesis by RALDH2 is essential for the development of posterior pharyngeal arches and the enteric nervous system , 2003, Development.

[53]  David Botstein,et al.  The Stanford Microarray Database: data access and quality assessment tools , 2003, Nucleic Acids Res..

[54]  Stephen W. Wilson,et al.  Retinoic acid signalling in the zebrafish embryo is necessary during pre-segmentation stages to pattern the anterior-posterior axis of the CNS and to induce a pectoral fin bud. , 2002, Development.

[55]  D. Bostwick,et al.  Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization. , 1997, Cancer research.